POLISCOPE
Back to feed
SB 1556FLORIDA · STATEWIDESession 2026dead

Proposed Experimental Treatment Access Trust Fund

Original title: Experimental Treatment Access Trust Fund/Department of Health

March 13, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The bill establishes a dedicated funding mechanism to assist patients with the high costs of accessing experimental medical procedures, contingent upon the passage of related legislation.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Florida residents

Patients seeking experimental treatments may receive financial assistance for travel and care costs.

Licensed experimental treatment centers

These facilities must either contribute 2% of net annual profits to the fund or provide an equivalent value in free care.

Department of Health

The department is responsible for managing the fund and adopting rules for center contributions.

What changed

Last recorded activity March 13, 2026.

What's next

Introduced.

Background

  • SB 1556 was introduced during the 2026 legislative session but failed to advance out of the Health Policy committee. context

Summary

This bill would create a new state to help Florida residents cover travel and care costs associated with experimental medical treatments. The fund would be financed by contributions from licensed experimental treatment centers, which could choose to donate 2% of their or provide an equivalent value in free care.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is eligible for assistance from this fund?
Eligible patients who are residents of Florida.
How is the fund paid for?
Licensed experimental treatment centers contribute 2% of their from experimental treatments or provide an equivalent amount of free care.
When does the fund expire?
The fund is scheduled to terminate on July 1, 2030, unless it is re-created following a legislative review.

Why It Matters

The bill establishes a dedicated funding mechanism to assist patients with the high costs of accessing experimental medical procedures, contingent upon the passage of related legislation.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Contingent Legislation Requirement

The bill's implementation is explicitly tied to the passage of other, unnamed legislation, creating a dependency that prevents it from functioning as a standalone policy.

Connected Entities

Sources

Open source document

openstates.org

Analysis Score

0–100
  • Significance45
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record